| Alexander Jasper Huynh, | |
|
218 E Highway 246 Bldg 3, Buellton, CA 93427-9654 | |
| (805) 693-1132 | |
| Not Available |
| Full Name | Alexander Jasper Huynh |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 218 E Highway 246 Bldg 3, Buellton, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881384667 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 84397 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alexander Jasper Huynh, 1115 S Reseda St, Anaheim, CA 92806-4921 Ph: () - | Alexander Jasper Huynh, 218 E Highway 246 Bldg 3, Buellton, CA 93427-9654 Ph: (805) 693-1132 |
News Archive
Countries in Latin America "are bracing this year for a particularly virulent outbreak of the mosquito-borne tropical disease" known as dengue fever, after reports show an increase in the number of cases recorded this year, Agence France-Presse reports. "The Pan-American Health Organization (PAHO) said so far it has logged some 146,000 cases in the first three months of the year, of which 79 have been fatal. This time last year there were some 79,000 cases of dengue reported, with 26 deaths," the news service writes.
Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use point-of-care diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed an agreement with Portola Pharmaceuticals, Inc. to develop and supply the VerifyNow System and VerifyNowTests for use in clinical trials.
After the first ever MediSens conference, 2016, it is fair to say that there is much excitement in the area of medical imaging. The industry is experiencing a drive towards a more personalized approach to healthcare, providing patients with treatment that is specific and adaptive to them.
St. Jude Medical, Inc., a global medical device company, today announced Japanese Ministry of Health, Labour and Welfare approval and reimbursement approval of its Therapy Cool Path Ablation Catheter. This marks the company's first entry into the irrigated catheter ablation market in Japan.
The Non-Small Cell Lung Cancer treatment market will be driven primarily by the introduction of numerous premium therapies, particularly in second-line and squamous cell treatment settings, which either replace or combine with generic chemotherapies.
› Verified 5 days ago
Julia Ferriol, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 218 E Highway 246 Bldg 3, Buellton, CA 93427 Phone: 805-693-1132 | |
Ahmed Abdelazeem, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 218 E Highway 246 Bldg 3, Buellton, CA 93427 Phone: 805-693-1132 | |
Dr. Tamara Mitterer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 218 E Highway 246 # 3, Buellton, CA 93427 Phone: 805-693-1132 Fax: 805-683-1707 | |
Britt Vivian Christensen, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 218 E Highway 246, Buellton, CA 93427 Phone: 213-742-6849 |